Compare VanEck Uranium & Nuclear ETF (NLR) vs Roivant Sciences Ltd. Common Shares (ROIV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
VanEck Uranium & Nuclear ETF vs Roivant Sciences Ltd. Common Shares — how do they compare? VanEck Uranium & Nuclear ETF trades at $103.53 (market cap $3.51B), while Roivant Sciences Ltd. Common Shares trades at $35.44 (market cap $24.72B). The key difference: Roivant Sciences Ltd. Common Shares is far larger — about 7× VanEck Uranium & Nuclear ETF's market cap, and Roivant Sciences Ltd. Common Shares is trading nearer its 52-week high, VanEck Uranium & Nuclear ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold VanEck Uranium & Nuclear ETF for 8 Days and Roivant Sciences Ltd. Common Shares for 1 Days on average.
| NLR | ROIV | |
|---|---|---|
Market Cap | $3.51B | $24.72B |
Volume | 414,516 | 6,279,442 |
Sector | Sector/Thematic | Health |
52-Week High | $164.37 | $41.81 |
52-Week Low | $102.38 | $16.04 |
Typical Hold Time | 8 Days | 1 Days |
Enterprise Value | — | $20.99B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About VanEck Uranium & Nuclear ETF
VanEck Uranium and Nuclear ETF seeks exposure to companies involved in uranium mining and the nuclear power industry. Its holdings may include miners, utilities, reactor-related companies, and nuclear equipment or service providers.
Read more on NLR →About Roivant Sciences Ltd. Common Shares
Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →
